HDAC6 as a novel candidate in the treatment of Inflammatory Breast Cancers
Inflammatory Breast Cancer (IBC) is a rare, lethal, and understudied form of breast cancer. Although affecting 1-2% of the population, the remission rate is half that of the spectrum of other breast cancers, and most cases present in the advanced stages due to rapid undetectable development. Of the...
| Main Author: | |
|---|---|
| Language: | English |
| Published: |
2015
|
| Subjects: | |
| Online Access: | https://doi.org/10.7916/D81835KX |